ArticleTherapeutic advances in medical oncology2025

Anti-programmed death-1 inhibitors and nimotuzumab in combination with induction chemotherapy for locoregionally advanced nasopharyngeal carcinoma: a propensity score-matched analysis.

Ya-Ni Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.